Piperacillin And Tazobactam And Sodium Chloride Injection, Solution
Product Images NDC 0264-3448

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Piperacillin And Tazobactam And Sodium Chloride (NDC 0264-3448). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by B. Braun Medical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Diagram 1 (Piperacillin And Tazobactam For Injection And Sodi 1)

FDA Label Image

3450-22 Container Label (Piperacillin And Tazobactam For Injection And Sodi 10)

3450-22 Container Label (Piperacillin And Tazobactam For Injection And Sodi 10)
This text provides detailed information about a medication called Piperacillin and Tazobactam for injection USP, containing Sodium Chloride Injection USP. It provides instructions on how to use the medication after mixing the contents of both chambers, dosage information, storage conditions, and precautions to be taken before and after reconstitution. It also mentions the composition of the medication, usage guidelines, expiration date, and manufacturing details.*
FDA Label Image

Diagram 2 (Piperacillin And Tazobactam For Injection And Sodi 2)

FDA Label Image

Diagram 3 (Piperacillin And Tazobactam For Injection And Sodi 3)

FDA Label Image

Diagram 4 (Piperacillin And Tazobactam For Injection And Sodi 4)

FDA Label Image

Diagram 5 (Piperacillin And Tazobactam For Injection And Sodi 5)

FDA Label Image

Chemical Structure Illustration Of Piperacillin Sodium (Piperacillin And Tazobactam For Injection And Sodi 6)

FDA Label Image

Chemical Structure Illustration Of Tazobactam Sodium (Piperacillin And Tazobactam For Injection And Sodi 7)

FDA Label Image

3446-11 Container Label (Piperacillin And Tazobactam For Injection And Sodi 8)

3446-11 Container Label (Piperacillin And Tazobactam For Injection And Sodi 8)
This text is a detailed description of the medicine Piperacillin and Tazobactam for Injection USP and Sodium Chloride Injection USP. It includes information on how to mix the contents, dosage, storage conditions, and guidelines for reconstitution and administration. The medication is intended for intravenous infusion and should be used within a certain timeframe after reconstitution. It also mentions that the product should be checked for clarity before use and should not be used if leaks are found. Additionally, it provides details on the total sodium content and the approximate osmolality of the solution. This medication is prepared in Italy and has specific lot and NDC numbers for identification.*
FDA Label Image

3448-11 Container Label (Piperacillin And Tazobactam For Injection And Sodi 9)

3448-11 Container Label (Piperacillin And Tazobactam For Injection And Sodi 9)
This is a description of the medication Piperacillin and Tazobactam for Injection USP in a DUPLEX® CONTAINER which must be used only after mixing the contents of both chambers. The medication is meant for intravenous infusion as a single dose. Each dry powder chamber provides specific amounts of Piperacillin, Tazobactam, edetate disodium, and sodium citrate. After reconstitution, each 50 mL single-dose DUPLEX® unit contains the medication and 0.9% sodium chloride injection. The total sodium content is 256 mg. The approximate osmolality is 348 mOsmol/kg. Before reconstitution, store the medication within the specified temperature range. After reconstitution, use within 24 hours if stored at room temperature or within 7 days if stored under refrigeration. Check for leaks before administration. Do not freeze or introduce additives into the container. This product is not made with natural rubber latex.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.